Teerlink, J. R. Et Al. 2021. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. NEW ENGLAND JOURNAL OF MEDICINE , vol.384, no.2 , 105-116.

Teerlink, J. R., Diaz, R., Felker, G. M., Mcmurray, J. J. V., Metra, M., Solomon, S. D., ... Adams, K. F.(2021). Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. NEW ENGLAND JOURNAL OF MEDICINE , vol.384, no.2, 105-116.

Teerlink, John Et Al. "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure," NEW ENGLAND JOURNAL OF MEDICINE , vol.384, no.2, 105-116, 2021

Teerlink, John R. Et Al. "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure." NEW ENGLAND JOURNAL OF MEDICINE , vol.384, no.2, pp.105-116, 2021

Teerlink, J. R. Et Al. (2021) . "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure." NEW ENGLAND JOURNAL OF MEDICINE , vol.384, no.2, pp.105-116.

@article{article, author={John R. Teerlink Et Al. }, title={Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2021, pages={105-116} }